Europe - Euronext Paris - EPA:ALGEN - FR0004053510 - Common Stock
We assign a fundamental rating of 4 out of 10 to ALGEN. ALGEN was compared to 83 industry peers in the Biotechnology industry. ALGEN has an average financial health and profitability rating. ALGEN is quite expensive at the moment. It does show a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.31% | ||
| ROE | 7% | ||
| ROIC | 3.17% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.97% | ||
| PM (TTM) | 6.14% | ||
| GM | 94.91% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.73 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.41 | ||
| Quick Ratio | 2.21 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16 | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.21 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EPA:ALGEN (1/14/2026, 7:00:00 PM)
2.4
-0.03 (-1.23%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16 | ||
| Fwd PE | N/A | ||
| P/S | 1.09 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.24 | ||
| P/tB | 1.84 | ||
| EV/EBITDA | 8.21 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.31% | ||
| ROE | 7% | ||
| ROCE | 3.94% | ||
| ROIC | 3.17% | ||
| ROICexc | 3.17% | ||
| ROICexgc | 3.91% | ||
| OM | 5.97% | ||
| PM (TTM) | 6.14% | ||
| GM | 94.91% | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.88 | ||
| Cap/Depr | 297.91% | ||
| Cap/Sales | 46.7% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.41 | ||
| Quick Ratio | 2.21 | ||
| Altman-Z | 1.73 |
ChartMill assigns a fundamental rating of 4 / 10 to ALGEN.PA.
ChartMill assigns a valuation rating of 2 / 10 to GENOWAY SA (ALGEN.PA). This can be considered as Overvalued.
GENOWAY SA (ALGEN.PA) has a profitability rating of 5 / 10.
The Price/Earnings (PE) ratio for GENOWAY SA (ALGEN.PA) is 16 and the Price/Book (PB) ratio is 1.24.
The financial health rating of GENOWAY SA (ALGEN.PA) is 4 / 10.